We are live on ! Find out more
SM

Sabby Management Portfolio holdings

AUM $45.1M
1-Year Est. Return 74.25%
This Fund
S&P 500
This Quarter Est. Return
+5.54%
1 Year Est. Return
-74.25%
3 Year Est. Return
-95.86%
5 Year Est. Return
-99.36%
10 Year Est. Return
-99.46%
AUM
$173M
AUM Growth
+$73.3M
Cap. Flow
+$11.6M
Cap. Flow %
6.67%
Top 10 Hldgs %
96.13%
Holding
83
New
26
Increased
11
Reduced
13
Closed
29

Sector Composition

Rank Sector Weight
1 Healthcare 5.65%
2 Technology 1.24%
3 Materials 0.46%
4 Industrials 0.37%
5 Energy 0.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BRSHW
76
DELISTED
Bruush Oral Care Inc. Warrant
BRSHW
-177,542
Closed -$1.21K
GGE
77
DELISTED
Green Giant Inc. Common Stock
GGE
-3,267,444
Closed -$171K
NEPT
78
DELISTED
Neptune Wellness Solutions Inc. Ordinary Shares
NEPT
-194,606
Closed -$104K
GMBLZ
79
DELISTED
Esports Entertainment Group Inc. Warrant
GMBLZ
-4,590,196
Closed -$23K
TBLT
80
DELISTED
ToughBuilt Industries, Inc. Common Stock
TBLT
-1,630
Closed -$16.7K
RIBT
81
DELISTED
RiceBran Technologies
RIBT
-225,850
Closed -$52.5K
TIO
82
PUT
DELISTED
Tingo Group, Inc. Common Stock
TIO
-160
Closed -$11K

Similar funds

Sabby Management's Q1 2024 Portfolio in Review

As of Q1 2024, Sabby Management held 83 positions worth $173M, up 73% from $100M the previous quarter. Its ten largest holdings account for 96% of the portfolio.

Sabby Management deployed $11.6M of net new capital in Q1 2024, opening 26 new positions and adding to 11 existing holdings. Its largest new stake was Vivani Medical: 2,673,018 shares worth $4.95M.

By sector, the portfolio is most concentrated in Healthcare at 5.6% of assets, up from 3.8% a quarter earlier, followed by Technology and Materials.

On the sell side, the largest reduction was Akari Therapeutics, an estimated $279K trimmed.

  • Sabby Management's largest Q1 2024 buy was Vivani Medical: 2,673,018 shares worth $4.95M.
  • Sabby Management added most to Femto Technologies Inc. Common Stock in Q1 2024, an estimated $2.65M increase.
  • Sabby Management's biggest Q1 2024 reduction was Akari Therapeutics, cutting an estimated $279K.
  • Sabby Management fully exited Meta Materials Inc. Common Stock in Q1 2024, selling an estimated $904K.
  • Sabby Management's ten largest holdings make up 96% of its $173M portfolio in Q1 2024.
  • Sabby Management opened 26 new positions and closed 29 in Q1 2024.
  • Sabby Management's portfolio value rose 73% quarter-over-quarter to $173M.

Based on Sabby Management's 13F filing for Q1 2024, filed 15 May 2024.